Mark R Walter

9PUBLICATIONS
31CO-AUTHORS
Nanotoxicology, health and safetyMedical virologyMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 09, 2026
A bireporter recombinant SARS-CoV-2 Omicron BA.5 for in vitro and in vivo studies.

Esteban M Castro, Ramya S Barre, Chengjin Ye

|Nov 24, 2025
A cocktail of SARS-CoV-2 spike stem helix domain and receptor binding domain human monoclonal antibodies prevent the emerge of viral escape mutants.

Yao Ma, Chengjin Ye, Michael S Piepenbrink

|May 15, 2024
Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variants.

Michael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang

|Nov 04, 2023
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology.

Daniel N Streblow, Alec J Hirsch, Jeffrey J Stanton

|Apr 04, 2023
Structure and epitope of a neutralizing monoclonal antibody that targets the stem helix of β coronaviruses.

Ashlesha Deshpande, Nobert Schormann, Mike S Piepenbrink

Pageof 2